Dendritic Cell-Based Immunotherapy for Prostate Cancer
Dendritic cells (DCs) are professional antigen-presenting cells (APCs), which display an extraordinary capacity to induce, sustain, and regulate T-cell responses providing the opportunity of DC-based cancer vaccination strategies. Thus, clinical trials enrolling prostate cancer patients were conduct...
| 出版年: | Clinical and Developmental Immunology |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2010-01-01
|
| オンライン・アクセス: | http://dx.doi.org/10.1155/2010/517493 |
